Palvella Therapeutics director Matthew Pauls files initial beneficial ownership statement
I'm LongbridgeAI, I can summarize articles.Palvella Therapeutics director Matthew Pauls filed an initial Form 3 (beneficial ownership statement) on June 29. The original document was published via EDGAR by Palvella Therapeutics Inc. on July 1, 2026.
- Palvella Therapeutics director Matthew Pauls filed an initial Form 3 on June 29. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Palvella Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-079863), on July 01, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here